Asthmatic reaction induced by Etoricoxib in a patient with aspirin-sensitive asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 63, Issue 8, 2008, Pages 1093-1094

  Koschel, D ^a   Cardoso, C ^b   Leucht, V ^b   Hoffken, G ^b  

^a Fachkrankenhaus Coswig   (Germany)

^b NONE

Author keywords

Aspirin; Asthma; Drug allergy; Etoricoxib; Ral challenge

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CAFFEINE PLUS PARACETAMOL; CELECOXIB; COPYRKAL; CORTICOSTEROID; DIPYRONE; ETORICOXIB; HISTAMINE H1 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; PREDNISOLONE; THEOPHYLLINE; UNCLASSIFIED DRUG; PROSTAGLANDIN SYNTHASE INHIBITOR; PYRIDINE DERIVATIVE; SULFONE;

ANAMNESIS; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; ASTHMA; CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFECT; DRUG MEGADOSE; DRUG TOLERABILITY; DYSPNEA; HUMAN; LOW DRUG DOSE; LUNG FUNCTION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RHINORRHEA; TREATMENT RESPONSE; URTICARIA; WHEEZING; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HOSPITALIZATION; MIDDLE AGED;

ANAPHYLAXIS; ASPIRIN; ASTHMA; CYCLOOXYGENASE INHIBITORS; FEMALE; HUMANS; MIDDLE AGED; PYRIDINES; SEVERITY OF ILLNESS INDEX; SULFONES;

EID: 56149106761     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2008.01782.x     Document Type: Article

References (6)

1. Szcezeklik E, Nizankowska E, Bochenek G, Nagraba K, Mejza F, Swierczynska M. Safety of a specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy 2001;31:219-225.
2. Stevenson DD, Simon RA. Lack of cross- reactivity between Rofecoxib and aspirin in aspirin-sensitive patients with asthma. J Allergy Clin Immunol 2001;108:47-51.
3. Woessner KM, Simon RA, Stevenson DD. The safety of Celecoxib in patients with aspirin-sensitive asthma. Arthritis Rheum 2002;46:2201-2206.
4. Sanches-Borges M, Caballero-Fonseca F, Capriles-Hulett A. Safety of Etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug- induced urticaria and angioedema. Ann Allergy Asthma Immunol 2005;95:154-158.
5. Viola M, Quaratino D, Gaeta C, Caruso C, Valluzzi R, Romano A. Etoricoxib tolearbility in patients with hypersensitivity to nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol 2007;143:103-108.
6. Nahar IK, Muqim AT, Al-Qhouti BI, Al-Herz AA, Shehab DK, Uppal SS et al. The use of Etoricoxib in patients with bronchial asthma associated with aspirin sensitivity. Saudi Med J 2006;27:119-120.